stella
beta
Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma — Stella
Recruiting
Back to T Cell Lymphoma trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(2 sites)
United States
Yale Cancer Center, Clinical Trials Office, New Haven, Connecticut
Icahn School of Medicine at Mount Sinai, New York, New York
View full record on ClinicalTrials.gov